271 related articles for article (PubMed ID: 24428606)
1. Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.
Molloy K; Hersh CP; Morris VB; Carroll TP; O'Connor CA; Lasky-Su JA; Greene CM; O'Neill SJ; Silverman EK; McElvaney NG
Am J Respir Crit Care Med; 2014 Feb; 189(4):419-27. PubMed ID: 24428606
[TBL] [Abstract][Full Text] [Related]
2. Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups.
Foreman MG; Wilson C; DeMeo DL; Hersh CP; Beaty TH; Cho MH; Ziniti J; Curran-Everett D; Criner G; Hokanson JE; Brantly M; Rouhani FN; Sandhaus RA; Crapo JD; Silverman EK;
Ann Am Thorac Soc; 2017 Aug; 14(8):1280-1287. PubMed ID: 28380308
[TBL] [Abstract][Full Text] [Related]
3. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
Piitulainen E; Mostafavi B; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
[TBL] [Abstract][Full Text] [Related]
4. Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline.
Mehta AJ; Thun GA; Imboden M; Ferrarotti I; Keidel D; Künzli N; Kromhout H; Miedinger D; Phuleria H; Rochat T; Russi EW; Schindler C; Schwartz J; Vermeulen R; Luisetti M; Probst-Hensch N;
Occup Environ Med; 2014 Apr; 71(4):234-40. PubMed ID: 24213563
[TBL] [Abstract][Full Text] [Related]
5. SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort.
Thun GA; Ferrarotti I; Imboden M; Rochat T; Gerbase M; Kronenberg F; Bridevaux PO; Zemp E; Zorzetto M; Ottaviani S; Russi EW; Luisetti M; Probst-Hensch NM
PLoS One; 2012; 7(8):e42728. PubMed ID: 22912729
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Rare
Ortega VE; Li X; O'Neal WK; Lackey L; Ampleford E; Hawkins GA; Grayeski PJ; Laederach A; Barjaktarevic I; Barr RG; Cooper C; Couper D; Han MK; Kanner RE; Kleerup EC; Martinez FJ; Paine R; Peters SP; Pirozzi C; Rennard SI; Woodruff PG; Hoffman EA; Meyers DA; Bleecker ER;
Am J Respir Crit Care Med; 2020 Mar; 201(5):540-554. PubMed ID: 31661293
[No Abstract] [Full Text] [Related]
7. Longitudinal decline of diffusing capacity of the lung for carbon monoxide in community subjects with the PiMZ alpha1-antitrypsin phenotype.
Silva GE; Guerra S; Keim S; Barbee RA; Sherrill DL
Chest; 2008 May; 133(5):1095-100. PubMed ID: 18263681
[TBL] [Abstract][Full Text] [Related]
8. IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.
Demeo DL; Campbell EJ; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard SI; Sandhaus RA; Stocks JM; Stoller JK; Strange C; Turino G; Silverman EK
Am J Respir Cell Mol Biol; 2008 Jan; 38(1):114-20. PubMed ID: 17690329
[TBL] [Abstract][Full Text] [Related]
9. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
[TBL] [Abstract][Full Text] [Related]
10. α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts.
Sørheim IC; Bakke P; Gulsvik A; Pillai SG; Johannessen A; Gaarder PI; Campbell EJ; Agustí A; Calverley PM; Donner CF; Make BJ; Rennard SI; Vestbo J; Wouters EF; Paré PD; Levy RD; Coxson HO; Lomas DA; Hersh CP; Silverman EK
Chest; 2010 Nov; 138(5):1125-32. PubMed ID: 20595457
[TBL] [Abstract][Full Text] [Related]
11. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.
Dahl M; Tybjaerg-Hansen A; Lange P; Vestbo J; Nordestgaard BG
Ann Intern Med; 2002 Feb; 136(4):270-9. PubMed ID: 11848724
[TBL] [Abstract][Full Text] [Related]
12. Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency.
Franciosi AN; Hobbs BD; McElvaney OJ; Molloy K; Hersh C; Clarke L; Gunaratnam C; Silverman EK; Carroll TP; McElvaney NG
Am J Respir Crit Care Med; 2020 Jul; 202(1):73-82. PubMed ID: 32197047
[No Abstract] [Full Text] [Related]
13. Maximal mid-expiratory flow detects early lung disease in α
Stockley JA; Ismail AM; Hughes SM; Edgar R; Stockley RA; Sapey E
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28356373
[TBL] [Abstract][Full Text] [Related]
14. An association between plasma levels of α2-macroglobulin and α1-antitrypsin in PiMM and PiZZ individuals differing in COPD presentation.
Lechowicz U; Martinez-Delgado B; Liu B; Wrenger S; Rozy A; Zdral A; DeLuca DS; Welte T; Janciauskiene S; Chorostowska-Wynimko J
Clin Biochem; 2024 Apr; 126():110736. PubMed ID: 38428450
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal study of alpha1-antitrypsin phenotypes and decline in FEV1 in a community population.
Silva GE; Sherrill DL; Guerra S; Barbee RA
Chest; 2003 May; 123(5):1435-40. PubMed ID: 12740258
[TBL] [Abstract][Full Text] [Related]
16. Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects.
Malerba M; Ricciardolo F; Radaeli A; Torregiani C; Ceriani L; Mori E; Bontempelli M; Tantucci C; Grassi V
Thorax; 2006 Feb; 61(2):129-33. PubMed ID: 16284217
[TBL] [Abstract][Full Text] [Related]
17. Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.
Demeo DL; Sandhaus RA; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard S; Burchard E; Stocks JM; Stoller JK; Strange C; Turino GM; Campbell EJ; Silverman EK
Thorax; 2007 Sep; 62(9):806-13. PubMed ID: 17389752
[TBL] [Abstract][Full Text] [Related]
18. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.
Silverman EK; Chapman HA; Drazen JM; Weiss ST; Rosner B; Campbell EJ; O'DONNELL WJ; Reilly JJ; Ginns L; Mentzer S; Wain J; Speizer FE
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1770-8. PubMed ID: 9620904
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values.
Pérez-Rubio G; Jiménez-Valverde LO; Ramírez-Venegas A; Camarena Á; Sansores RH; Flores-Trujillo F; Reséndiz-Hernández JM; Falfán-Valencia R
Arch Bronconeumol; 2015 Feb; 51(2):80-85. PubMed ID: 25454901
[TBL] [Abstract][Full Text] [Related]
20. COPD in individuals with the PiMZ alpha-1 antitrypsin genotype.
Al Ashry HS; Strange C
Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29070580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
